ANNX
Annexon Inc
NASDAQ: ANNX · HEALTHCARE · BIOTECHNOLOGY
$5.87
-0.34% today
Updated 2026-04-30
Market cap
$943.59M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.34
Dividend yield
—
52W range
$2 – $7
Volume
2.7M
Annexon Inc (ANNX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-19.26M | $-17.19M | $-28.36M | $-53.09M | $-106.11M | $-116.31M | $-121.14M | $-118.01M | $-186.36M |
| Capital expenditures | $567000.00 | $17000.00 | $267000.00 | $464000.00 | $1.65M | $6.53M | $193000.00 | $15000.00 | $137000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $401000.00 | $408000.00 | $2.04M | $4.89M | $16.26M | $18.52M | $18.18M | $19.43M | $16.42M |
| Free cash flow | $-19.83M | $-17.21M | $-28.63M | $-53.55M | $-107.76M | $-122.83M | $-121.33M | $-118.02M | $-186.49M |
| Investing cash flow | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | $102.52M | — | — | — | — | $1.86M |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $224.63M | $-192.55M | $65.04M | — | — | — |